Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2025-01-06 Purchase | 2025-01-08 4:32 pm | Acurx Pharmaceuticals Inc. | ACXP | Scodari Joseph C Director | 24,631 | $1.015 | $25,000 | 52,339 (Direct) | View |
2025-01-06 Purchase | 2025-01-08 4:31 pm | Acurx Pharmaceuticals Inc. | ACXP | Sailer Carl Director | 24,631 | $1.015 | $25,000 | 166,814 (Indirect Direct) | View |
2025-01-06 Purchase | 2025-01-08 4:31 pm | Acurx Pharmaceuticals Inc. | ACXP | LUCI DAVID P President and CEO 10% Owner | 49,261 | $1.015 | $50,000 | 1,196,802 (Indirect Direct) | View |
2025-01-06 Purchase | 2025-01-08 4:31 pm | Acurx Pharmaceuticals Inc. | ACXP | Donohue James J. Director | 9,852 | $1.015 | $10,000 | 32,204 (Direct) | View |
2025-01-06 Purchase | 2025-01-08 4:30 pm | Acurx Pharmaceuticals Inc. | ACXP | DELUCCIA ROBERT J Director 10% Owner | 49,261 | $1.015 | $50,000 | 1,063,304 (Indirect Direct) | View |
2025-01-06 Purchase | 2025-01-08 4:30 pm | Acurx Pharmaceuticals Inc. | ACXP | DEAN JACK H Director | 9,852 | $1.015 | $10,000 | 37,398 (Indirect Direct) | View |
2022-07-27 Purchase | 2022-07-29 5:02 pm | Acurx Pharmaceuticals Inc. | ACXP | Sailer Carl Director | 19,737 | $3.8 | $75,001 | 137,289 (Indirect Direct) | View |
2022-07-27 Purchase | 2022-07-29 5:02 pm | Acurx Pharmaceuticals Inc. | ACXP | DELUCCIA ROBERT J Director 10% Owner | 19,737 | $3.8 | $75,001 | 1,094,519 (Indirect Direct) | View |
2022-07-27 Purchase | 2022-07-29 5:01 pm | Acurx Pharmaceuticals Inc. | ACXP | LUCI DAVID P President and CEO 10% Owner | 19,737 | $3.8 | $75,001 | 1,118,017 (Indirect Direct) | View |
2021-11-23 Purchase | 2021-11-24 4:06 pm | Acurx Pharmaceuticals Inc. | ACXP | Sailer Carl Director | 5,161 | $4.84 | $24,979 | 78,078 (Indirect Direct) | View |
2021-11-19 Purchase | 2021-11-22 4:05 pm | Acurx Pharmaceuticals Inc. | ACXP | DELUCCIA ROBERT J Director 10% Owner | 5,034 | $4.901 | $24,672 | 1,035,308 (Indirect Direct) | View |
2021-11-19 Purchase | 2021-11-22 4:05 pm | Acurx Pharmaceuticals Inc. | ACXP | LUCI DAVID P President and CEO 10% Owner | 5,200 | $4.8 | $24,960 | 1,058,806 (Indirect Direct) | View |
2021-06-29 Purchase | 2021-09-10 4:16 pm | Acurx Pharmaceuticals Inc. | ACXP | Sailer Carl Director | 12,500 | $6 | $75,000 | 72,917 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2025-02-05 Option Award | 2025-02-06 5:47 pm | N/A 2035-02-05 | Acurx Pharmaceuticals Inc. | ACXP | Shawah Robert G. Chief Financial Officer | 145,500 | $0 | 145,500 (Direct) | View |
2025-02-05 Option Award | 2025-02-06 5:46 pm | N/A 2035-02-05 | Acurx Pharmaceuticals Inc. | ACXP | LUCI DAVID P President and CEO 10% Owner | 250,000 | $0 | 250,000 (Direct) | View |
2025-02-05 Option Award | 2025-02-06 5:45 pm | N/A 2035-02-05 | Acurx Pharmaceuticals Inc. | ACXP | DELUCCIA ROBERT J Director 10% Owner | 250,000 | $0 | 250,000 (Direct) | View |
2024-06-17 Option Award | 2024-06-18 4:15 pm | N/A 2034-06-17 | Acurx Pharmaceuticals Inc. | ACXP | Scodari Joseph C Director | 12,000 | $0 | 12,000 (Direct) | View |
2024-06-17 Option Award | 2024-06-18 4:14 pm | N/A 2034-06-17 | Acurx Pharmaceuticals Inc. | ACXP | Sailer Carl Director | 12,000 | $0 | 12,000 (Direct) | View |
2024-06-17 Option Award | 2024-06-18 4:12 pm | N/A 2034-06-17 | Acurx Pharmaceuticals Inc. | ACXP | HARRISON THOMAS L Director | 12,000 | $0 | 12,000 (Direct) | View |
2024-06-17 Option Award | 2024-06-18 4:11 pm | N/A 2034-06-17 | Acurx Pharmaceuticals Inc. | ACXP | Donohue James J. Director | 12,000 | $0 | 12,000 (Direct) | View |
2024-06-17 Option Award | 2024-06-18 4:10 pm | N/A 2034-06-17 | Acurx Pharmaceuticals Inc. | ACXP | DEAN JACK H Director | 12,000 | $0 | 12,000 (Direct) | View |
2024-02-23 Option Award | 2024-04-03 9:56 pm | N/A 2034-02-22 | Acurx Pharmaceuticals Inc. | ACXP | LUCI DAVID P President and CEO 10% Owner | 250,000 | $0 | 250,000 (Direct) | View |
2024-02-23 Option Award | 2024-04-03 9:56 pm | N/A 2034-02-22 | Acurx Pharmaceuticals Inc. | ACXP | Shawah Robert G. Chief Financial Officer | 145,000 | $0 | 145,000 (Direct) | View |
2024-02-23 Option Award | 2024-04-03 9:55 pm | N/A 2034-02-22 | Acurx Pharmaceuticals Inc. | ACXP | DELUCCIA ROBERT J Director 10% Owner | 250,000 | $0 | 250,000 (Direct) | View |
2024-01-19 Exercise | 2024-01-22 06:15 am | N/A N/A | Acurx Pharmaceuticals Inc. | ACXP | Sailer Carl Director | 19,737 | $3.55 | 117,552 (Direct) | View |
2024-01-19 Exercise | 2024-01-22 06:15 am | 2023-01-27 2024-01-27 | Acurx Pharmaceuticals Inc. | ACXP | Sailer Carl Director | 19,737 | $0 | 117,552 (Direct) | View |
2021-12-02 Gift | 2024-01-04 4:26 pm | N/A N/A | Acurx Pharmaceuticals Inc. | ACXP | DELUCCIA ROBERT J Director 10% Owner | 110,000 | $0 | 964,782 (Direct) | View |
2024-01-03 Exercise | 2024-01-04 4:26 pm | N/A N/A | Acurx Pharmaceuticals Inc. | ACXP | DELUCCIA ROBERT J Director 10% Owner | 19,737 | $3.55 | 964,782 (Direct) | View |
2024-01-03 Exercise | 2024-01-04 4:26 pm | 2023-01-27 2024-01-27 | Acurx Pharmaceuticals Inc. | ACXP | DELUCCIA ROBERT J Director 10% Owner | 19,737 | $0 | 964,782 (Direct) | View |
2024-01-03 Exercise | 2024-01-04 4:24 pm | N/A N/A | Acurx Pharmaceuticals Inc. | ACXP | LUCI DAVID P President and CEO 10% Owner | 19,737 | $3.55 | 1,098,280 (Direct) | View |
2024-01-03 Exercise | 2024-01-04 4:24 pm | 2023-01-27 2024-01-27 | Acurx Pharmaceuticals Inc. | ACXP | LUCI DAVID P President and CEO 10% Owner | 19,737 | $0 | 1,098,280 (Direct) | View |
2023-06-15 Option Award | 2023-06-16 5:46 pm | N/A 2033-06-15 | Acurx Pharmaceuticals Inc. | ACXP | Donohue James J. Director | 10,000 | $0 | 10,000 (Direct) | View |
2023-06-15 Option Award | 2023-06-16 5:46 pm | N/A 2033-06-15 | Acurx Pharmaceuticals Inc. | ACXP | HARRISON THOMAS L Director | 10,000 | $0 | 10,000 (Direct) | View |
2023-06-15 Option Award | 2023-06-16 5:45 pm | N/A 2033-06-15 | Acurx Pharmaceuticals Inc. | ACXP | DEAN JACK H Director | 10,000 | $0 | 10,000 (Direct) | View |
2023-06-15 Option Award | 2023-06-16 5:45 pm | N/A 2033-06-15 | Acurx Pharmaceuticals Inc. | ACXP | Sailer Carl Director | 10,000 | $0 | 10,000 (Direct) | View |
2023-06-15 Option Award | 2023-06-16 5:45 pm | N/A 2033-06-15 | Acurx Pharmaceuticals Inc. | ACXP | Scodari Joseph C Director | 10,000 | $0 | 10,000 (Direct) | View |
2023-02-13 Option Award | 2023-02-24 4:32 pm | N/A 2033-02-12 | Acurx Pharmaceuticals Inc. | ACXP | Shawah Robert G. Chief Financial Officer | 75,000 | $0 | 75,000 (Direct) | View |
2023-02-13 Option Award | 2023-02-24 4:31 pm | N/A 2033-02-12 | Acurx Pharmaceuticals Inc. | ACXP | LUCI DAVID P President and CEO 10% Owner | 130,000 | $0 | 130,000 (Direct) | View |
2023-02-13 Option Award | 2023-02-24 4:30 pm | N/A 2033-02-12 | Acurx Pharmaceuticals Inc. | ACXP | DELUCCIA ROBERT J Director 10% Owner | 130,000 | $0 | 130,000 (Direct) | View |
2021-07-01 Option Award | 2021-07-06 4:15 pm | N/A 2031-06-30 | Acurx Pharmaceuticals Inc. | ACXP | Scodari Joseph C Director | 50,000 | $0 | 50,000 (Direct) | View |
2021-07-01 Option Award | 2021-07-06 4:13 pm | N/A 2031-06-30 | Acurx Pharmaceuticals Inc. | ACXP | Sailer Carl Director | 50,000 | $0 | 50,000 (Direct) | View |
2021-07-01 Option Award | 2021-07-06 4:13 pm | N/A 2031-06-30 | Acurx Pharmaceuticals Inc. | ACXP | HARRISON THOMAS L Director | 50,000 | $0 | 50,000 (Direct) | View |
2021-07-01 Option Award | 2021-07-06 4:12 pm | N/A 2031-06-30 | Acurx Pharmaceuticals Inc. | ACXP | Donohue James J. Director | 50,000 | $0 | 50,000 (Direct) | View |
2021-07-01 Option Award | 2021-07-06 4:11 pm | N/A 2031-06-30 | Acurx Pharmaceuticals Inc. | ACXP | DEAN JACK H Director | 50,000 | $0 | 50,000 (Direct) | View |